{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:17:47Z","timestamp":1794655067471,"version":"4.9.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,20]]},"abstract":"<jats:p>Antibody-related immune phenotypes reflect long-term host\u2013pathogen interactions and immunogenetic regulation, and have been increasingly implicated in cancer susceptibility. In ovarian cancer, observational associations between immune responses and disease risk remain difficult to interpret due to confounding and potential reverse causation. Genetic analyses may help clarify whether specific antibody immune response profiles are linked to ovarian cancer risk. We investigated the associations between 46 genetically predicted antibody immune response phenotypes and ovarian cancer using a 2-sample Mendelian randomization framework. Genetic instruments for antibody traits were obtained from large genome-wide association studies, while ovarian cancer summary statistics were derived independently from the FinnGen R12 and OpenGWAS resources. Causal estimates were derived primarily using inverse-variance weighted models and subsequently synthesized across datasets to improve precision. Multiple testing adjustment was applied, and additional analyses were conducted to assess robustness and causal directionality. Across the evaluated antibody phenotypes, most showed no evidence of a causal association with ovarian cancer risk. After meta-analysis and correction for multiple comparisons, genetically predicted anti-polyomavirus 2 immunoglobulin G (IgG) seropositivity was associated with a modest increase in ovarian cancer risk (odds ratio\u2005=\u20051.062, 95% confidence interval: 1.027\u20131.099). Sensitivity analyses did not indicate substantial pleiotropic bias, and reverse-direction analyses provided no support for ovarian cancer influencing anti-polyomavirus 2 IgG levels. These findings suggest that genetic liability to anti-polyomavirus 2 IgG seropositivity, as a marker of immune response rather than active infection, is modestly associated with ovarian cancer risk in individuals of European ancestry. Although the effect size is small, the results highlight a potential role for antibody-mediated immune processes in ovarian cancer etiology and warrant further investigation in diverse populations and experimental settings.<\/jats:p>","DOI":"10.1097\/md.0000000000047824","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T23:00:37Z","timestamp":1771628437000},"page":"e47824","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Genetic evidence linking anti-polyomavirus 2 IgG seropositivity to ovarian cancer risk"],"prefix":"10.1097","volume":"105","author":[{"given":"Weichu","family":"Zhang","sequence":"first","affiliation":[{"name":"Key Laboratory of Reproductive Dysfunction Management of Zhejiang Province and Nursing Department, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuorong","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Song","sequence":"additional","affiliation":[{"name":"Key Laboratory of Reproductive Dysfunction Management of Zhejiang Province and Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohan","family":"Zou","sequence":"additional","affiliation":[{"name":"Key Laboratory of Reproductive Dysfunction Management of Zhejiang Province and Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7770-547X","authenticated-orcid":false,"given":"Shihao","family":"Hong","sequence":"additional","affiliation":[{"name":"Key Laboratory of Reproductive Dysfunction Management of Zhejiang Province and Department of Obstetrics and Gynecology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260523","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13048-024-01461-w","article-title":"Comprehensive analysis of hub genes associated with cisplatin-resistance in ovarian cancer and screening of therapeutic drugs through bioinformatics and experimental validation.","volume":"17","author":"Zhu","year":"2024","journal-title":"J Ovarian Res"},{"key":"R2-20260523","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13048-024-01386-4","article-title":"Identification and validation of IRF6 related to ovarian cancer and biological function and prognostic value.","volume":"17","author":"Hong","year":"2024","journal-title":"J Ovarian Res"},{"key":"R3-20260523","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(15)01024-7","article-title":"Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect.","volume":"387","author":"Victora","year":"2016","journal-title":"Lancet (London, England)"},{"key":"R4-20260523","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","article-title":"Global epidemiology of epithelial ovarian cancer.","volume":"21","author":"Webb","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"R5-20260523","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/10937400701876095","article-title":"Risk factors for ovarian cancer: an overview with emphasis on hormonal factors.","volume":"11","author":"Salehi","year":"2008","journal-title":"J Toxicol Environ Health Part B"},{"key":"R6-20260523","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10549-005-9051-5","article-title":"Influence of selected lifestyle factors on breast and ovarian cancer risk in BRCA1 mutation carriers from Poland.","volume":"95","author":"Gronwald","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"R7-20260523","doi-asserted-by":"crossref","first-page":"6532","DOI":"10.3390\/ijms22126532","article-title":"Ovarian cancer immunotherapy and personalized medicine.","volume":"22","author":"Morand","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R8-20260523","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12943-022-01588-8","article-title":"Potential clinical utility of liquid biopsies in ovarian cancer.","volume":"21","author":"Zhu","year":"2022","journal-title":"Mol Cancer"},{"key":"R9-20260523","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s12905-024-03186-w","article-title":"The levels of women\u2019s awareness, experience, acceptability and preference for vaginal human papillomavirus (HPV) self-sampling in three provinces of China: a cross-sectional study.","volume":"24","author":"Song","year":"2024","journal-title":"BMC Womens Health"},{"key":"R10-20260523","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer.","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet (London, England)"},{"key":"R11-20260523","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/S0140-6736(21)00731-5","article-title":"Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.","volume":"397","author":"Menon","year":"2021","journal-title":"Lancet (London, England)"},{"key":"R12-20260523","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/jjco\/hyv014","article-title":"Pharmacotherapy for recurrent ovarian cancer: current status and future perspectives.","volume":"45","author":"Matsumoto","year":"2015","journal-title":"Jpn J Clin Oncol"},{"key":"R13-20260523","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1158\/1078-0432.CCR-18-3603","article-title":"Clinical and molecular predictors of response to immune checkpoint inhibitors in patients with advanced esophagogastric cancer.","volume":"25","author":"Greally","year":"2019","journal-title":"Clin Cancer Res"},{"key":"R14-20260523","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/humupd\/dmae020","article-title":"Ovarian microenvironment: challenges and opportunities in protecting against chemotherapy-associated ovarian damage.","volume":"30","author":"Guo","year":"2024","journal-title":"Hum Reprod Update"},{"key":"R15-20260523","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jacc.2020.10.048","article-title":"Diet-derived circulating antioxidants and risk of coronary heart disease: a mendelian randomization study.","volume":"77","author":"Luo","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R16-20260523","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12916-023-02761-6","article-title":"Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study.","volume":"21","author":"Long","year":"2023","journal-title":"BMC Med"},{"key":"R17-20260523","doi-asserted-by":"crossref","first-page":"1285106","DOI":"10.3389\/fimmu.2023.1285106","article-title":"Exploring causal correlations between inflammatory cytokines and ankylosing spondylitis: a bidirectional mendelian-randomization study.","volume":"14","author":"Fang","year":"2023","journal-title":"Front Immunol"},{"key":"R18-20260523","doi-asserted-by":"crossref","first-page":"1315099","DOI":"10.3389\/fendo.2023.1315099","article-title":"Application and discoveries of metabolomics and proteomics in the study of female infertility.","volume":"14","author":"Shi","year":"2024","journal-title":"Front Endocrinol"},{"key":"R19-20260523","doi-asserted-by":"crossref","first-page":"3090797","DOI":"10.1155\/2024\/3090797","article-title":"Causal relationships between homocysteine and the polycystic ovary syndrome: a mendelian randomization analysis.","volume":"2024","author":"Lin","year":"2024","journal-title":"Int J Endocrinol"},{"key":"R20-20260523","doi-asserted-by":"crossref","first-page":"ofaa450","DOI":"10.1093\/ofid\/ofaa450","article-title":"Genetic determinants of antibody-mediated immune responses to infectious diseases agents: a genome-wide and HLA association study.","volume":"7","author":"Butler-Laporte","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"R21-20260523","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R22-20260523","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/ng.3826","article-title":"Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.","volume":"49","author":"Phelan","year":"2017","journal-title":"Nat Genet"},{"key":"R23-20260523","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method.","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R24-20260523","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"eLife"},{"key":"R25-20260523","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa054693","article-title":"Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy.","volume":"354","author":"Yousry","year":"2006","journal-title":"N Engl J Med"},{"key":"R26-20260523","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s13365-023-01164-w","article-title":"Revisiting JC virus and progressive multifocal leukoencephalopathy.","volume":"29","author":"Rocchi","year":"2023","journal-title":"J Neurovirol"},{"key":"R27-20260523","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s11481-019-09877-8","article-title":"Host-Immune Interactions in JC virus reactivation and development of progressive multifocal leukoencephalopathy (PML).","volume":"14","author":"Khalili","year":"2019","journal-title":"J Neuroimmune Pharmacol"},{"key":"R28-20260523","doi-asserted-by":"crossref","first-page":"120459","DOI":"10.1016\/j.jns.2022.120459","article-title":"Progressive multifocal leukoencephalopathy in anti-CD20 and other monoclonal antibody (mAb) therapies used in multiple sclerosis: a review.","volume":"443","author":"Sharma","year":"2022","journal-title":"J Neurol Sci"},{"key":"R29-20260523","first-page":"276","article-title":"Polyoma BK virus: an emerging opportunistic infectious agent of the human central nervous system.","volume":"15","author":"Lopes da Silva","year":"2011","journal-title":"Braz J Infect Dis"},{"key":"R30-20260523","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study.","volume":"5","author":"Fitzmaurice","year":"2019","journal-title":"JAMA Oncol"},{"key":"R31-20260523","doi-asserted-by":"crossref","first-page":"103995","DOI":"10.1016\/j.msard.2022.103995","article-title":"Use of natalizumab in persons with multiple sclerosis: 2022 update.","volume":"65","author":"Morrow","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"R32-20260523","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1038\/sj.onc.1206559","article-title":"Human neurotropic polyomavirus, JCV, and its role in carcinogenesis.","volume":"22","author":"Khalili","year":"2003","journal-title":"Oncogene"},{"key":"R33-20260523","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrc3728","article-title":"Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions.","volume":"14","author":"Steenbergen","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"R34-20260523","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13027-017-0122-0","article-title":"Review on the role of the human polyomavirus JC in the development of tumors.","volume":"12","author":"Delbue","year":"2017","journal-title":"Infect Agents Cancer"},{"key":"R35-20260523","doi-asserted-by":"crossref","first-page":"976577","DOI":"10.3389\/fonc.2022.976577","article-title":"The oncogenic roles of JC polyomavirus in cancer.","volume":"12","author":"Zheng","year":"2022","journal-title":"Front Oncol"},{"key":"R36-20260523","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00403-024-03703-9","article-title":"Genetic association between human skin microbiota with vaginitis: a two-sample Mendelian randomization study.","volume":"317","author":"Zhang","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"R37-20260523","doi-asserted-by":"crossref","first-page":"3090797","DOI":"10.1155\/2024\/3090797","article-title":"Causal relationships between homocysteine and the polycystic ovary syndrome: a Mendelian randomization analysis.","volume":"2024","author":"Lin","year":"2024","journal-title":"Int J Endocrinol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T23:00:13Z","timestamp":1779577213000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047824","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"2025-10-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}